PDS Biotechnology Corp (PDSB) stock
PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.78−0.11 (-12.27%)
Close on Nov 18, 2026Market cap $43.89MP/E –Yield –
PDS Biotechnology operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
PDS Biotechnology's operating cash flow for the twelve months ending Jun 30, 2026 was -$16.78M. For fiscal 2025 it was -$27.75M. The highest annual figure on record is -$1.57M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$27.75M | – |
| FY2024 | Dec 31, 2024 | -$35.03M | – |
| FY2023 | Dec 31, 2023 | -$33.64M | – |
| FY2022 | Dec 31, 2022 | -$25.71M | – |
| FY2021 | Dec 31, 2021 | -$12.49M | – |
| FY2020 | Dec 31, 2020 | -$13.15M | – |
| FY2019 | Dec 31, 2019 | -$18.07M | – |
| FY2018 | Dec 31, 2018 | -$1.57M | – |
| FY2017 | Dec 31, 2017 | -$40.70M | – |
| FY2016 | Dec 31, 2016 | -$32.19M | – |
| FY2015 | Dec 31, 2015 | -$21.75M | – |
| FY2014 | Dec 31, 2014 | -$9.72M | – |
| FY2013 | Dec 31, 2013 | -$8.04M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.79M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.37M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.70M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.92M | – |
| Q2 FY2025 | Jun 30, 2025 | -$9.10M | – |
| Q1 FY2025 | Mar 31, 2025 | -$9.03M | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.23M | – |
| Q3 FY2024 | Sep 30, 2024 | -$8.00M | – |
| Q2 FY2024 | Jun 30, 2024 | -$8.86M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.94M | – |
| Q4 FY2023 | Dec 31, 2023 | -$8.46M | – |
| Q3 FY2023 | Sep 30, 2023 | -$7.18M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.81M | – |
| Q1 FY2023 | Mar 31, 2023 | -$13.19M | – |
| Q4 FY2022 | Dec 31, 2022 | -$7.53M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.89M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.92M | -725.5% |
| Q1 FY2022 | Mar 31, 2022 | -$6.37M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.50M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.13M | – |
| Q2 FY2021 | Jun 30, 2021 | $946.23K | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.80M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.63M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.25M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.10M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.16M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.52M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.33M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.86M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.37M | – |
| Q4 FY2018 | Dec 31, 2018 | -$317.63K | – |
| Q3 FY2018 | Sep 30, 2018 | -$432.25K | – |
| Q2 FY2018 | Jun 30, 2018 | -$415.37K | – |
| Q1 FY2018 | Mar 31, 2018 | -$404.34K | – |
| Q4 FY2017 | Dec 31, 2017 | -$9.24M | – |
| Q3 FY2017 | Sep 30, 2017 | -$11.40M | – |
| Q2 FY2017 | Jun 30, 2017 | -$9.28M | – |
| Q1 FY2017 | Mar 31, 2017 | -$10.77M | – |
| Q4 FY2016 | Dec 31, 2016 | -$6.05M | – |
| Q3 FY2016 | Sep 30, 2016 | -$8.79M | – |
See a number that looks wrong?